Project cooperationUpdated on 8 October 2025
Hybrid molecular an anatomical imaging
CEO & CTO HYBRIMS at HYBRIMS
Valencia, Spain
About
Perform clinical validation studies on PET+MRI+ultrasound prostate fusion biopsy for reducing false negatives and false positives, thus improving cancer diagnosis
Similar opportunities
Partnership
Hybrid molecular an anatomical imaging
Luis Caballero
CEO & CTO HYBRIMS at HYBRIMS
Valencia, Spain
Request
IVD and Pharma Companies - early stage cancer detection
Bernhard Nussbaumer
Shareholder & CBDO at ACMIT Gmbh
Wiener Neustadt, Austria
Expertise
Performance Evaluation Plan for IVD
- MEDICINE
- BIOLOGY / BIOTECHNOLOGY
- INDUSTRIAL BIOTECHNOLOGY
Vincent GENTY
CEO at Amarok Biotechnologies
Pleslin Trigavou, France